Therapy options in cutaneous T-cell lymphoma
- 1 October 2001
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 1 (3) , 403-420
- https://doi.org/10.1586/14737140.1.3.403
Abstract
The treatment of cutaneous T-cell lymphoma (CTCL) is continually evolving, as new and emerging drugs are added to the growing arsenal of CTCL therapy. The availability of newly approved investigational therapies, such as bexarotene, denileukin diftitox (DAB389- IL2), monoclonal antibodies and novel chemotherapeutic agents, adds complexity to decisions on the management and treatment of CTCL patients. In formulating a treatment plan, therapeutic options are best approached through consideration of overall clinical staging (stage IA-IVB) and skin staging (T1-T4), which affect prognosis and the characteristics of each individual patient's disease. This article will present and discuss the optimal therapeutic agents for all clinical stages of CTCL patients, based on currently available and investigational agents.Keywords
This publication has 23 references indexed in Scilit:
- Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.American Journal of Public Health, 1999
- Central Hypothyroidism Associated with Retinoid X Receptor–Selective LigandsNew England Journal of Medicine, 1999
- Interferon-α Induced Thyroid Dysfunction: Three Clinical Presentations and a Review of the LiteratureThyroid®, 1997
- Clinical Stage IA (Limited Patch and Plaque) Mycosis FungoidesArchives of Dermatology, 1996
- Combined modality therapy for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell LymphomaArchives of Dermatology, 1995
- Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapyJournal of the American Academy of Dermatology, 1992
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesNew England Journal of Medicine, 1989
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987
- Intralesional interferon in the treatment of early mycosis fungoidesJournal of the American Academy of Dermatology, 1985